Compare XBIT & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIT | BCML |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.1M | 364.8M |
| IPO Year | 2015 | 2018 |
| Metric | XBIT | BCML |
|---|---|---|
| Price | $2.17 | $30.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 43.1K | 37.3K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.09% |
| EPS Growth | N/A | ★ 3.81 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | N/A | $5.25 |
| P/E Ratio | ★ N/A | $275.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $26.78 |
| 52 Week High | $3.44 | $34.98 |
| Indicator | XBIT | BCML |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 43.77 |
| Support Level | N/A | $29.57 |
| Resistance Level | $2.46 | $30.89 |
| Average True Range (ATR) | 0.05 | 0.55 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 23.53 | 33.57 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.